Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2335]

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

Aspirin and smoking affect ageing of genes

Aspirin and smoking affect ageing of genes

Genetics dominant risk factor in common cancers

Genetics dominant risk factor in common cancers

ESMO GI: Cetuximab or bevacizumab with combi chemo equivalent in KRAS wile-type metastic colorectal cancer

ESMO GI: Cetuximab or bevacizumab with combi chemo equivalent in KRAS wile-type metastic colorectal cancer

$ESMO GI: Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to standard therapies$

ESMO GI: Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to...

ASCO 2014: First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer

ASCO 2014: First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in...

20 years of the European Institute of Oncology

20 years of the European Institute of Oncology

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

Open-access publishing has contributed to Africa's research output

Open-access publishing has contributed to Africa's research output

Scientists identify cancer specific cell for potential targeted treatment of gastric cancer

Scientists identify cancer specific cell for potential targeted treatment of gastric cancer

More from ecancer